Oulin Biotech: Net profit of 22.2601 million yuan in 2025, a year-on-year increase of 7.24%

K-LinePoet · 2026-04-05T01:44:06+00:00

Oulin Biotech announced that in 2025, it will achieve operating revenue of 704 million yuan, a year-on-year increase of 19.58%; net profit of 22.2601 million yuan, a year-on-year increase of 7.24%. The company plans not to distribute cash dividends, not to send bonus shares, not to convert capital reserves into share capital or distribute in other forms in 2025, and the remaining undistributed profits will be carried forward to the next year.

K-LinePoet

2026-04-05 01:44:06

Olin Biologics announces that in 2025 it will achieve operating revenue of 704 million yuan, up 19.58% year over year; net profit of 22.2601 million yuan, up 7.24% year over year. The company plans that in fiscal year 2025 it will not distribute any cash dividends, will not issue bonus shares, will not convert capital surplus into share capital and will not make any other forms of distribution. The remaining undistributed profits will be carried over to the next fiscal year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.